Company: SRPT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001193125-25-269436
Chunk: 14

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part II, Item 6
Chunk 14
---
The exhibits listed on the Exhibit Index immediately preceding such exhibits, which is incorporated herein by reference, are filed or furnished as part of this Quarterly Report on Form 10-Q. 

EXHIBIT INDEX

     Incorporated by Reference toFilings Indicated

     ExhibitNumber
      
     Exhibit Description
      
     Form
      
     FileNo.
      
     Exhibit
      
     FilingDate
      
     ProvidedHerewith

        3.1
      
     Amended and Restated Certificate of Incorporation.
      
     8-K12B
      
     001-14895
      
     3.1
      
     6/6/13

        3.2
      
     Amendment to the Amended and Restated Certificate of Incorporation.
      
     8-K
      
     001-14895
      
     3.1
      
     6/30/15

        3.3
      
     Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Sarepta Therapeutics, Inc.
      
     8-K
      
     001-14895
      
     3.1
      
     6/8/20

        3.4
      
     Second Amended and Restated Bylaws
      
     8-K
      
     001-14895
      
     3.1
      
     12/13/22

        3.5
      
     Amendment No. 1 to the Second Amended and Restated Bylaws
      
     8-K
      
     001-14895
      
     3.1
      
     9/16/24

        4.1
      
     Indenture, dated as of August 28, 2025, by and between Sarepta Therapeutics, Inc. and U.S. Bank Trust Company, National Association (including the form of the 4.875% Convertible Senior Note due 2030)
      
     8-K 
      
     001-14895 
      
     4.1
      
     8/29/25

        10.1†
      
     General Release and Separation and Consulting Agreement with Dallan Murray

     X